 The VIAjectTM-08J study is the efficacy and safety study for insulin VIAjectTM to demonstrate equivalent blood glucose control in patients with type 2 diabetes mellitus with VIAjectTM insulin or regular human insulin as prandial insulin and to demonstrate an equivalent safety profile for VIAjectTM in comparison to human insulin. 